Why Is Leidos (LDOS) Down 6.7% Since Last Earnings Report?

Leidos (LDOS) shares have declined 6.7% since its last earnings report, underperforming the S&P 500, with estimates trending downward over the past month. Despite this recent underperformance, Leidos holds a Zacks Rank #2 (Buy), suggesting an expected above-average return in the coming months. In comparison, Cognizant (CTSH), a peer in the IT Services industry, has gained 2.3% over the past month and also holds a Zacks Rank #2 (Buy).

Analysis

Leidos (LDOS) has demonstrated recent market underperformance, with its shares declining 6.7% since its last earnings report, lagging the S&P 500, a period during which analyst estimates have also trended downwards. Despite this, Leidos currently holds a Zacks Rank #2 (Buy), indicating an expectation of above-average returns in the forthcoming months, supported by an overall VGM Score of B, which includes a B for value, though C grades for growth and momentum suggest mixed underlying factor performance. In contrast, industry peer Cognizant (CTSH) has appreciated 2.3% over the past month, reporting a 7.5% year-over-year revenue increase to $5.12 billion and an EPS of $1.23 in its latest quarter, with analysts projecting a 6.8% EPS rise for the current quarter. Cognizant also carries a Zacks Rank #2 (Buy) and a VGM Score of B, with Zacks Consensus Estimates remaining unchanged over the last 30 days, reflecting greater stability and positive per-ticker sentiment (0.7 for CTSH vs. 0.2 for LDOS).

Key Decisions for Investors

• Investors should consider Leidos' recent 6.7% share price decline and downward estimate revisions in the context of its Zacks Rank #2 (Buy) and B-grade for value, which may signal a potential mispricing if the negative sentiment is short-term.
• Cognizant's positive momentum, evidenced by a 2.3% share gain, strong Q1 revenue growth of 7.5% YoY, and consistent #2 Buy rating, presents a comparatively stable investment within the IT services sector for those seeking current fundamental strength.
• Monitoring upcoming earnings reports and any changes in analyst estimate trends for Leidos will be crucial in evaluating whether its "Buy" rating translates into a near-term stock recovery or reflects a longer-term outlook.